secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0000310764-23-000104
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q2 2023: Net sales +11.2% to $5.0B; adj. EPS $2.54; raises FY organic growth outlook to 9.5%-10.5%
--------------------------------------------------------------------------------

- Net sales $5.0B, +11.2% reported, +11.9% organic; adj. EPS $2.54 (+12.9%).
- MedSurg & Neurotechnology $2.9B (+12.9% organic); Orthopaedics & Spine $2.1B (+10.6% organic).
- Reported op margin 19.3%; adjusted op margin 24.3% (up 60bps).
- FY2023 organic sales growth guidance raised to 9.5%-10.5%; adj EPS guidance $10.25-$10.45.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076423000104/0000310764-23-000104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076423000104/syk-20230803.htm
  HTML page:      https://secwatch.observer/filing/0000310764-23-000104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer